HIV-1 genetic diversity and reverse transcriptase resistance mutations in Benin before dolutegravir era, West Africa
PLOS One · 21.05.2026 · 21 (5) · e0348800
DOI: 10.1371/journal.pone.0348800 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 21.05.2026. Verfasst von Edmond Tchiakpe und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cell Biology and Physiology, Department of Biochemistry and Cellular Biology, Faculty of Sciences and Technology (FAST) and Institute o…. Hauptthemen laut MEDLINE: HIV-1, Drug Resistance, Viral, HIV Infections, Mutation. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Benin adopted the World Health Organization’s (WHO) “Test and Treat” recommendation in 2016 and, since 2019, has updated this protocol by including dolutegravir (DTG) as the preferred first-line treatment. Study aimed to assess the prevalence of virological failure (VL > 3log copies/mL) and review genetic diversity and antiretroviral resistance mutations in patients on antiretroviral treatment for at least 12 months before dolutegravir Era in Benin. Cross-sectional study included patient plasmas from antiretroviral treatment sites nationwide. Viral load was performed in National Reference Laboratory of Health Program Fighting Against AIDS using the Cobas® 5800 HIV-1 assay. For plasmas those VL above 1000 copies/mL, nested PCR were done along the entire protease and part of reverse transcriptase. The DNA obtained by the Sanger method was used to determine the subtypes of HIV-1 after editing with DNASTAR SeqMan Pro™ and alignment with ClustalW2 version 2.1. Phylogenetic trees were constructed by the Neighbor-Joining method and recombinants were investigated by bootscanning with Seaview software version 2.1. DNA was subjected to the Stanford University Antiretroviral Resistance Mutation Interpretation Algorithm ( https://hivdb.stanford.edu/ ) to identify the positions of drug-associated resistance mutations. (178/253; 70.35%) of the samples were correctly amplified and sequenced. CRF02_AG (n = 104) was the predominant strain observed followed by CRF06_cpx (n = 21), G (n = 5), CRF43_02G (n = 2), CRF37_cpx (n = 2), A1 (n = 1) and unique recombinant forms (URFs) (n = 34) among the 169 samples sequenced on entire protease combined with part of the reverse transcriptase. (164/178; 92.1%), (141/178; 79.2%), (160/178; 89.9%) and (7/169; 4.1%) patients carried at least one drug resistance associated to NRTIs, NNRTIs and PIs respectively. M184I/V, TAMSI: (M41L, L210W, T215Y) and TAMSII: (D67N, K70R, K219Q/E, T215I/V) represented (71.3%), (21.9%), (35.4%) respectively. K103N/S was the most preponderant mutations encountered with a proportion of 64.6% followed by V179E (21.3%), P225H (20.2%), V108I (19.1%), Y181C (16.3%), A98G (15.2%), V106I/M/A (10.1%). I84V (1.8%) mutation was the major associated PIs encountered followed by L90M, V82A, M46I each encountered twice (1.2%) and I47A, V32I, I54V, G48A, each encountered once (0.6%). Study shows a high genetic diversity with the presence of new strains and underlines the need to regularly review data on genetic diversity and resistance among patients receiving antiretroviral therapy in the country.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Cell Biology and Physiology, Department of Biochemistry and Cellular Biology, Faculty of Sciences and Technology (FAST) and Institute of Applied Biomedical Sciences (ISBA), University of Abomey-Calavi, Cot…
- National Reference Laboratory of Health Program Fighting Against AIDS in Benin (LNR/PSLS), Health Ministry of Benin, Cotonou, Benin.
- Health Program Fighting Against AIDS in Benin, Cotonou, Benin.
- UMR5234 MFP, University of Bordeaux and Virology Laboratory, WHO HIV Center, CHU Bordeaux, France.
- Groupe de Recherche Biotechnologies Appliquées & Bioprocédés Environnementaux (GRBA-BE), Laboratoire Eau-Énergie-Environnement-Procédés-Industriels (LE3PI), École Supérieure Polytechnique (ESP), Université Cheikh Anta D…
- Institute of Human Virology, Nigeria, Plateau State, Abuja, Nigeria.
ORCID-Profile: Edmond Tchiakpe, Patricia Recordon-Pinson, Abou Abdallah Malick Diouara
Zitieren
APA
Tchiakpe, E., Keke, R. K., Recordon-Pinson, P., Diouara, A. A. M., Andreola, M. L., Bachabi, M., Afangnihoun, A., Gbaguidi, E., Osawe, S., Issiaka Maiga, A., Diop-Ndiaye, H., Touré-Kane, C., & Yessoufou, A. (2026). HIV-1 genetic diversity and reverse transcriptase resistance mutations in Benin before dolutegravir era, West Africa. PLOS One, 21(5), e0348800. https://doi.org/10.1371/journal.pone.0348800
Vancouver
Tchiakpe E, Keke RK, Recordon-Pinson P, Diouara AAM, Andreola ML, Bachabi M, et al. HIV-1 genetic diversity and reverse transcriptase resistance mutations in Benin before dolutegravir era, West Africa. PLOS One. 2026;21(5):e0348800. doi:10.1371/journal.pone.0348800
BibTeX
@article{Tchiakpe2026,
author = {Tchiakpe, Edmond and Keke, René Kpemahouton and Recordon-Pinson, Patricia and Diouara, Abou Abdallah Malick and Andreola, Marie-Line and Bachabi, Moussa and Afangnihoun, Aldric and Gbaguidi, Eric and Osawe, Sophia and Issiaka Maiga, Almoustapha and Diop-Ndiaye, Halimatou and Touré-Kane, Coumba and Yessoufou, Akadiri},
title = {HIV-1 genetic diversity and reverse transcriptase resistance mutations in Benin before dolutegravir era, West Africa},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {5},
pages = {e0348800},
doi = {10.1371/journal.pone.0348800}
}
EUVIMED